BioSpace News Archive

PharmaMar and Jazz Pharmaceuticals plc announce that the U.S. Food and Drug Administration accepted for filing with Priority Review the New Drug Application seeking accelerated approval for lurbinectedin for the treatment of patients with Small Cell Lung Cancer who have progressed after prior platinum-containing therapy.

Fresenius Kabi announces that the Journal of Parenteral and Enteral Nutrition has recently published “Lipids in Parenteral Nutrition: Translating Guidelines into Clinical Practice”.[1] The publication represents the largest set of expert consensus statements to provide guidance on the use of fish oil-containing lipid emulsions in clinical practice.

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced the Company’s Board of Directors has elected Robert Friel as its newest member.

YARDLEY, Pa., Feb. 17, 2020 (GLOBE NEWSWIRE) -- On February 7, 2020, Jubilant DraxImage Inc., and certain of its affiliates (“Jubilant”) were informed by the U.S. Patent Office that it agreed with Jubilant’s arguments that two rubidium-infusion-system patents owned by Bracco Diagnostics, Inc., (“Bracco”) are invalid. Bracco had alleged that Jubilant’s RUBY-FILL ® Generator and RUBY Rubidium Elution System™ were infringing the two patents in a lawsuit filed in 2018, prompting Jubilant to ch

Feb. 17, 2020 13:00 UTC ALLENDALE, Mich.--( BUSINESS WIRE )-- QST Consultations, Ltd. changed its name to Abond CRO Inc., launching the new brand via their website and participation at S.C.O.P.E ., February 18-21 in Orlando, FL. Since its founding in 1974 by John Quiring, PhD, QST Consultations has built long-standing partnerships with pharmaceutical and medical device companies by providing scientifically sound clinical trial evaluations. “Over the years we have had th

PRINCETON, N.J., Feb. 17, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immuno-oncology company developing multiple therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced that Dr. Frank Bedu-Addo, President and Chief Executive Officer and Dr. Lauren Wood, Chief Medical Officer are scheduled to participate in Noble Capital Markets’ 16 th Annual Small & Microcap Investor Conference being held on Februar

Feb. 17, 2020 13:01 UTC SAN DIEGO--( BUSINESS WIRE )-- Neuropore Therapies, Inc., a biopharmaceutical company discovering and developing novel therapeutics for the treatment of neurodegenerative disorders, announced today that it has been awarded a $500,000 grant from The ALS Association to support the preclinical evaluation and development of its leading Toll-Like Receptor 2 (TLR2) antagonist NPT1220-312 for the treatment of amyotrophic lateral sclerosis. The grant has been made

Three Northwell Health facilities – Lenox Health Greenwich Village, Mather Hospital in Port Jefferson and Plainview Hospital – have received approval this month from the New York State Health and Health Planning Council to establish cardiac catheterization labs, expanding access to critical cardiology services in Manhattan and Long Island.

RaySearch Laboratories AB (publ) has announced that Clínica El Rosario in Colombia has become the first RaySearch customer in South America to go live with treatment planning system RayStation® for Accuray’s Radixact® System.

Rimkus Consulting Group, Inc. (Rimkus), a worldwide provider of forensic engineering and consulting services, today announced the strategic acquisition of North Carolina-based Metallurgical Technologies, Inc. (Met-Tech), a metallurgical analysis and testing laboratory that specializes in rapid response forensic materials engineering.